PTGS2 and neoplasm: COX-independent pathways are also involved as the low doses of aspirin (< 500 mg/day) used here has little or no activity against COX-2.80 We propose that the reduced tumour-forming potential was also mediated by the suppression of inflammatory-associated signalling pathways involved in EMT, as evident by the concurrent reduction of mesenchymal marker expression.